Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of diabetic status on the hyperglycemia-induced adverse risk of short term outcomes in hospitalized patients with acute coronary syndromes in the Middle East: findings from the Gulf registry of Acute Coronary Events (Gulf RACE).
Thalib L, Zubaid M, Rashed W, Suwaidi JA, Almahmeed W, Alozairi E, Alanbaei M, Sulaiman K, Amin H, Al-Motarreb A. Thalib L, et al. Among authors: alozairi e. Clin Med Res. 2011 Mar;9(1):32-7. doi: 10.3121/cmr.2010.946. Epub 2010 Sep 17. Clin Med Res. 2011. PMID: 20852085 Free PMC article.
Erratum to 'Comment on "The effect of timing of remotely supervised exercise on glucose control in people with type 1 diabetes during Ramadan: A randomised crossover study" by Ozairi E et al.' [Diabetes Metabol Syndr: Clin Res Rev 18 (2) (February 2024) 102967].
Al Ozairi E, ElSamad A, Al Kandari J, Hamdan Y, Taliping D, Gray SR. Al Ozairi E, et al. Diabetes Metab Syndr. 2024 Mar;18(3):102999. doi: 10.1016/j.dsx.2024.102999. Epub 2024 Apr 4. Diabetes Metab Syndr. 2024. PMID: 38579488 No abstract available.
The double burden: Navigating type 1 diabetes and obesity.
Steenackers N, Feldman AN, Mathieu C, Rosen J, Soderberg J, Al-Ozairi E, le Roux CW, Van der Schueren B. Steenackers N, et al. Clin Obes. 2024 Jun;14(3):e12645. doi: 10.1111/cob.12645. Epub 2024 Feb 9. Clin Obes. 2024. PMID: 38334191 No abstract available.
Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial).
Al-Ozairi E, Narula K, Miras AD, Taghadom E, Samad AE, Al Kandari J, Alyosef A, Mashankar A, Al-Najim W, le Roux CW. Al-Ozairi E, et al. Trials. 2024 Feb 16;25(1):129. doi: 10.1186/s13063-024-07930-3. Trials. 2024. PMID: 38365744 Free PMC article.
The emergence of obesity in type 1 diabetes.
Kueh MTW, Chew NWS, Al-Ozairi E, le Roux CW. Kueh MTW, et al. Int J Obes (Lond). 2024 Mar;48(3):289-301. doi: 10.1038/s41366-023-01429-8. Epub 2023 Dec 14. Int J Obes (Lond). 2024. PMID: 38092958 Free PMC article. Review.
95 results